|
Reviews of Glucosamine Safety
D'Ambrosio E, Casa B, Bompani R, et al. Glucosamine
sulfate: A controlled investigation in arthrosis. Pharmatherapeutica.
1981 ;2:504-508.
Vaz AL. Double-blind clinical evaluation of the
relative efficiency of ibuprofen and glucosamine sulfate in the
management of osteoarthritis of the knee in out-patients. Curr Med
Res Opin. 1982;8:145-149.
Pujalte JM, Llavore EP, Ylescupidez FR. Double-blind
clinical evaluation of oral glucosamine sulfate in the basic treatment
of osteoarthritis. Curr Med Res Opin. 1980;7:110-114.
Gaulden FC, Keating WC. The effect of intravenous
N-acetyl-D-glucosamine on the blood and urine sugar concentrations
of normal subjects. Metabolism. 1964;13: 466--472.
Glucosamine Side Effects
McCarty ME The neglect of glucosamine as a treatment
for osteoarthritis--A personal perspective. Med Hypotheses. 1994;42:323-327.
Reichelt A, Forster KK, Fischer M, et al. Efficacy
and safety of intramuscular glucosamine sulfate in osteoarthritis
of the knee. A randomized, placebo-controlled, double-blind study.
Arzneim-Forsch DrugRes. 1994;44:75-80.
Weiden S, Wood IJ. The fate of glucosamine hydrochloride
injected intravenously in man. J Clin Pathol. 1958;11:343-349.
Levin RM, Krieger NN, Winzer RJ. Glucosamine and
acetylglucosamine tolerance in man. J Lab Clin Med. 1961 ;59:927-931.
Chondroitin Sulfate
Deal, CL: “Neutraceuticals as Therapeutic
Agents in Osteoarthritis.” Rheumatic Disease Clinics of North
America, May 1999; 379-395. Loes M: “Natural Medicine and
Pain Relievers: A Review.” Natural Medicine Online .
Chondroitin Sulfate: its in-vitro Effects on Human
Articular Chondrocytes Cultivated in Clusters. Bassleer C, Malaise
M, University of L B. 3rd, International Congress of the Osteoarthritis
Research Society Osteoarthritis in Focus: 5, Suppl A,:69. (1997)
Etude de pnase IV sur action des soses orales del
sulfate articulations. Crivelli E, Voy E D. Der informaierte Artz
Gazette Medicinale, 3. (1987)
Evaluation of the Chondroitin Sulfate Effects on
Chondrocytes' Cultures Placed in a Pressurization System. Nerucci
F, Fioravanti A, Bisogno S, Spinelli G, Marcolongo R. 3rd, International
Congress of the Osteoarthritis Research Society Osteoarthritis in
Focus: 5, Suppl A,:69, May (1997).
Vérification de l'action de l'acide Chondroitin
sulfurique chez des malades arthrosiques. Rovetta G, Monteforte
P, Molfetta G, Balestra V. (1972)
Rovetta G (1991): Galactosaminoglycuronoglycan
Sulfate (Matrix) in Therapy of Tibiofibular Osteoarthritis of The
Knee.drugs Exptl. Clin. Res. XVII (l) 53-57. Weyers W, Iseli D (1987):
Pharmakologische Untersuchungen zur antiphalogistische Wirksamkeit
Von Chondroitinsulfat. II Mitteilung. Therapiewoche Schweiz, 3,
864.
Effects Of An Oral Chondroprotective Agent (Cosequin)
Of Cartilage Metabolism And Canine Serum. McNamara PS, Barr SC,
Idouraine A, Lippiello L. Proceedings of the 24th Annual Conference
of the Veterinary Orthopedic Society, page 35, 1997.
Evaluation of the Clinical Efficacy of Cosequin
in the Treatment of Navicular Syndrome - a Double-Blinded Placebo
Controlled Randomized Clinical Trial. Hanson RR, Hammad TA, Brawner
WR. World Equine Veterinary Association 5th WEVA Congress Abstracts,
3:3:60, September 1997 and 1997 ACVS Veterinary Symposium Small
Animal Proceedings, pages 9-1 0, October 16-19, 1997.
Efficacy and Tolerability of 2 x 400 Mg Oral Chondroitin
Sulfate as a Single Dose in the Treatment of Knee Osteoarthritis.
Bucci L, Podr G et al. 3rd International Congress of the Osteoarthritis
Research Society Osteoarthritis in Focus: 5, Suppl A:69. (1997).
Hematologic, Hemostatic, and Biochemical Effects
In Dogs Receiving an Oral Chondroprotective Agent For Thirty Days.
McNamara PS, Barr SC, Erb HN. American Journal Veterinary Research,
57: 9:1390-1394, 1996.
Oral Treatment with a Glucosamine-Chondroitin Sulfate
Compound For Degenerative Joint Disease In Horses: 25 Cases. Hanson
RR, Smalley LR, Huff GK, White S, Hammad TA. Equine Practice, 19:9,
October 1997
Results Of A Survey Of Small Animals Practitioners
On The Perceived Clinical Efficacy And Safety Of An Oral Chondroprotective
Nutraceutical Anderson M, Slater M, Hammad TA. Proceedings of the
24th Annual Conference of the Veterinary Orthopedic Society, page
1, October 1997 and, 1997 ACVS Veterinary Symposium Small Animal
Proceedings, page 1, October 16-19, 1997.
Therapeutic Effect Of Cosamin® On Autoimmune
Type II Collagen Induced Arthritis In Rats. Baron J, Hill SL, Rose
NR. Proceedings of North American Veterinary Conference (Innovations
And New Product Applications In Veterinary Practice), page 35, January
1997.
Current Management of Equine Degenerative Joint
Diseases (Round Table 6). Turner T, Stone WC, Herthel D, Weinberg
C, Leitch M, Markell R. Equine Practice - Roundtable 19:7-8, July/August-September
1997.
Medical therapy of Osteoarthritis in Dogs. Boulay
JP, De Angelis M, Kincaid SA, Leeds EB, Prostredny JM, Todhunter
RJ. Veterinary Exchange, Roundtable, Supplement to Compendium, published
June 1995.
Animal Joint Disease
Roundtable - Degenerative Joint Disease in Dogs.
Boothe D, Camp R, Gelfand L, Ross G. Turkell A, Willer R. Canine
Practice, 21:1-4 January/February - July/August 1996.
Roundtable on Equine Degenerative Joint Disease
White N, Benner E, Grant B, Hanson RR, McNitt D, Mitchell R. Equine
Practice, 17:6, June 1995 Soothing Those Sore Joints. Kerwin S,
Anderson M, Aronson R, Beale B, Elkins AD, McCarthy R, Sams A. Veterinary
Forum - Roundtable on Canine Osteoarthritis, 14:10:55-61, October
1997.
Glucosamine and Condroitin Combined
Efficacy
Glycosaminoglycans in the Treatment of Degenerative
Joint Disease in Small Animals. Anderson MA, Beaver DP. Emerging
Science and Technology 2:3: 38-39, Summer 1996
Oral Glycosaminoglycans in the Treatment of Degenerative
Joint Disease in Horses. Hanson RR. Equine Practice, 18:10:18-22,
November/December 1996.
Promising Responses To A New Oral Treatment For
Degenerative Joint Disorder. Moore MG. Canine Practice, 21:2:7-1
1, March/April 1996.
Slow-Acting, Disease-Modifying Osteoarthritis Agents.
McNamara PS, Johnston SA, Todhunter RJ. Veterinary Clinics of North
America: Small Animal Practice, 27:4:863-867, 951-952, July 1997.
Schenk RC: “New Approaches to the Treatment
of Osteoarthritis: Oral Glucosamine and Chondroitin Sulfate.”
AAOS Instructional Course Lectures, Volume 49, 2000; 491-494.
Effects of the Treatment with Matrix on Elderly
People with Chronic Articular Degeneration. FA, Cerio R, Grasso
A M, Policicchio D, Di Grezia F, Sorrentino P, Lingetti M. Drugs
Exptl- Clin. Res. XVII (l) 45-51 (1991).
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Be sure to visit the Glucosamine Product Guide for a review of commercially available glucosamine products broken down by 9 different categories such as price per month, quality and type. Learn what the best products out there are and what criteria was used to ranked each.
|
